Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (21-30 of 361) with videos related to

Pageof 37
Sort By:
The Journal of Urology|October 21, 2003
Screening for prostate cancer: recommendation and rationalePatrick C Walsh
The Journal of Urology|October 22, 2003
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled studyPatrick C Walsh
The Journal of Urology|October 22, 2003
Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experiencePatrick C Walsh
Journal of the National Cancer Institute|November 1, 2018
RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective StudyPatrick C Walsh
The Journal of Urology|September 14, 2012
Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statementPatrick C Walsh
The Journal of Urology|August 14, 2012
Re: The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upPatrick C Walsh
The Journal of Urology|August 14, 2012
Re: Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPatrick C Walsh
The Journal of Urology|August 12, 2005
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?Patrick C Walsh
The Journal of Urology|September 8, 2005
Estimated impact of the prostate cancer prevention trial on population mortalityPatrick C Walsh
The Journal of Urology|September 8, 2005
Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomyPatrick C Walsh
Pageof 37

Showing results (21-30 of 361) with videos related to

Sort By:
Pageof 37
The Journal of Urology|October 21, 2003
Screening for prostate cancer: recommendation and rationalePatrick C Walsh
The Journal of Urology|October 22, 2003
Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled studyPatrick C Walsh
The Journal of Urology|October 22, 2003
Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experiencePatrick C Walsh
Journal of the National Cancer Institute|November 1, 2018
RE: Risk of Prostate Cancer in Men Treated With 5α-Reductase Inhibitors-A Large Population-Based Prospective StudyPatrick C Walsh
The Journal of Urology|September 14, 2012
Re: Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statementPatrick C Walsh
The Journal of Urology|August 14, 2012
Re: The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-upPatrick C Walsh
The Journal of Urology|August 14, 2012
Re: Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trialPatrick C Walsh
The Journal of Urology|August 12, 2005
Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?Patrick C Walsh
The Journal of Urology|September 8, 2005
Estimated impact of the prostate cancer prevention trial on population mortalityPatrick C Walsh
The Journal of Urology|September 8, 2005
Re: Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomyPatrick C Walsh
Pageof 37